- Title: Subtitle
- Final results from NSABP protocol R-04: Neoadjuvant chemoradiation (RT) comparing continuous infusion (CIV) 5-FU with capecitabine (Cape) with or without oxaliplatin (Ox) in patients with stage II and III rectal cancer
- Creators
- Carmen Joseph Allegra - University of FloridaGreg Yothers - University of PittsburghMichael J. O'Connell - NSABP FoundationMark S. Roh - Orlando HealthSamia H. Lopa - University of PittsburghNicholas J. Petrelli - NSABP, and Helen F. Graham Cancer Center & Research Institute, Newark, DERobert W. Beart - NSABP, and Glendale Memorial Hospital, Glendale, CASaima Sharif - NSABP FoundationNorman Wolmark - Allegheny General Hospital
- Resource Type
- Abstract
- Publication Details
- Journal of clinical oncology, Vol.32(15_suppl), pp.3603-3603
- DOI
- 10.1200/jco.2014.32.15_suppl.3603
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Language
- English
- Date published
- 05/20/2014
- Academic Unit
- Internal Medicine; Hematology, Oncology, and Blood & Marrow Transplantation
- Record Identifier
- 9984363186702771
Abstract
Final results from NSABP protocol R-04: Neoadjuvant chemoradiation (RT) comparing continuous infusion (CIV) 5-FU with capecitabine (Cape) with or without oxaliplatin (Ox) in patients with stage II and III rectal cancer
Journal of clinical oncology, Vol.32(15_suppl), pp.3603-3603
05/20/2014
DOI: 10.1200/jco.2014.32.15_suppl.3603
Details
Metrics
14 Record Views